Literature DB >> 19837156

Role of oxidative stress in vinorelbine-induced vascular endothelial cell injury.

Takaaki Yamada1, Nobuaki Egashira, Maiko Imuta, Takahisa Yano, Yui Yamauchi, Hiroyuki Watanabe, Ryozo Oishi.   

Abstract

Vinorelbine (VNR), a vinca alkaloid anticancer drug, often causes vascular injury such as venous irritation, vascular pain, phlebitis, and necrotizing vasculitis. The purpose of this study was to identify the mechanisms that mediate the cell injury induced by VNR in porcine aorta endothelial cells (PAECs). PAECs were exposed to VNR for 10 min followed by further incubation in serum-free medium without VNR. The exposure to VNR (0.3-30 microM) decreased the cell viability concentration and time dependently. The incidence of apoptotic cells significantly increased at 12 h after transient exposure to VNR. At the same time, VNR increased the activity of caspases. Interestingly, VNR rapidly depleted intracellular glutathione (GSH) and increased intracellular reactive oxygen species (ROS) production. Moreover, VNR depolarized the mitochondrial membrane potential and decreased cellular ATP levels. These VNR-induced cell abnormalities were almost completely inhibited by GSH and N-acetylcysteine. On the other hand, L-buthionine-(S,R)-sulfoximine, a specific inhibitor of GSH synthesis, aggravated the VNR-induced loss of cell viability. These results clearly demonstrate that VNR induces oxidative stress by depleting intracellular GSH and increasing ROS production in PAECs, and oxidative stress plays an important role in the VNR-induced cell injury. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19837156     DOI: 10.1016/j.freeradbiomed.2009.10.032

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  15 in total

1.  Decrease in the vinorelbine-induced venous irritation by pharmaceutical intervention.

Authors:  Takaaki Yamada; Nobuaki Egashira; Hiroyuki Watanabe; Kenichiro Nagata; Takahisa Yano; Toshiharu Nonaka; Ryozo Oishi
Journal:  Support Care Cancer       Date:  2011-07-31       Impact factor: 3.603

2.  Docetaxel Facilitates Endothelial Dysfunction through Oxidative Stress via Modulation of Protein Kinase C Beta: The Protective Effects of Sotrastaurin.

Authors:  Ching-Hsia Hung; Shih-Hung Chan; Pei-Ming Chu; Kun-Ling Tsai
Journal:  Toxicol Sci       Date:  2015-01-28       Impact factor: 4.849

3.  Induction of autophagy by salidroside through the AMPK-mTOR pathway protects vascular endothelial cells from oxidative stress-induced apoptosis.

Authors:  Xiang-Tao Zheng; Zi-Heng Wu; Ye Wei; Ju-Ji Dai; Guan-Feng Yu; FengLai Yuan; Le-Chi Ye
Journal:  Mol Cell Biochem       Date:  2016-11-15       Impact factor: 3.396

4.  Induction of oxidative stress by anticancer drugs in the presence and absence of cells.

Authors:  Chikako Yokoyama; Yuto Sueyoshi; Mika Ema; Yumi Mori; Kazuto Takaishi; Hisashi Hisatomi
Journal:  Oncol Lett       Date:  2017-09-14       Impact factor: 2.967

5.  Cyanidin-3-O-Glucoside Protects against 1,3-Dichloro-2-Propanol-Induced Reduction of Progesterone by Up-regulation of Steroidogenic Enzymes and cAMP Level in Leydig Cells.

Authors:  Jianxia Sun; Wei Xu; Cuijuan Zhu; Yunfeng Hu; Xinwei Jiang; Shiyi Ou; Zhijian Su; Yadong Huang; Rui Jiao; Weibin Bai
Journal:  Front Pharmacol       Date:  2016-11-04       Impact factor: 5.810

6.  Monotropein promotes angiogenesis and inhibits oxidative stress-induced autophagy in endothelial progenitor cells to accelerate wound healing.

Authors:  Chenggui Wang; Cong Mao; Yiting Lou; Jianxiang Xu; Qingqing Wang; Zengjie Zhang; Qian Tang; Xiaolei Zhang; Huazi Xu; Yongzeng Feng
Journal:  J Cell Mol Med       Date:  2017-12-26       Impact factor: 5.310

7.  Targeted release of stromal cell-derived factor-1α by reactive oxygen species-sensitive nanoparticles results in bone marrow stromal cell chemotaxis and homing, and repair of vascular injury caused by electrical burns.

Authors:  Fang He; Peng-Fei Luo; Tao Tang; Fang Zhang; He Fang; Shi-Zhao Ji; Yu Sun; Guo-Sheng Wu; Bo-Han Pan; Zhi-Bao Huo; Guang-Yi Wang; Zhao-Fan Xia
Journal:  PLoS One       Date:  2018-03-12       Impact factor: 3.240

Review 8.  Metronomic chemotherapy and anti-angiogenesis: can upgraded pre-clinical assays improve clinical trials aimed at controlling tumor growth?

Authors:  Klas Norrby
Journal:  APMIS       Date:  2013-10-26       Impact factor: 3.205

9.  The Cardiac Markers and Oxidative Stress Parameters in Advanced Non-Small Cell Lung Cancer Patients Receiving Cisplatin-Based Chemotherapy.

Authors:  Urszula Demkow; Beata Biatas-Chromiec; Anna Stelmaszczyk-Emmel; Elzbieta Radzikowska; Elzbieta Wiatr; Piotr Radwan-Rohrenschef; Monika Szturmowicz
Journal:  EJIFCC       Date:  2011-03-14

10.  Risk factors for venous irritation in patients receiving vinorelbine: a retrospective study.

Authors:  Yoshihito Morimoto; Kumika Miyawaki; Reisuke Seki; Kazuhiro Watanabe; Masayoshi Hirohara; Takao Shinohara
Journal:  J Pharm Health Care Sci       Date:  2018-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.